Jennie L. Conroy
Affiliations: | Albany Medical Center, Albany, NY, United States |
Area:
Pain researchGoogle:
"Jennie Conroy"Mean distance: 30533.1
Parents
Sign in to add mentor| Lindsay B. Hough | grad student | 2005-2010 | Albany Medical College of Union University | |
| (Characterization of the anti-morphine action of CC12: An epoxygenase theory of morphine antinociception.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Luderman KD, Conroy JL, Free RB, et al. (2018) Identification of positive allosteric modulators of the D1 dopamine receptor that act at diverse binding sites. Molecular Pharmacology |
| Luderman KD, Conroy JL, Free RB, et al. (2016) Structurally Diverse Positive Allosteric Modulators of the D1 Dopamine Receptor Potentiate G‐Protein and β‐Arrestin‐Mediated Signaling The Faseb Journal. 30 |
| Dix AV, Conroy JL, George Rosenker KM, et al. (2015) PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor. Acs Medicinal Chemistry Letters. 6: 425-9 |
| Conroy JL, Free RB, Sibley DR. (2015) Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor. Acs Chemical Neuroscience. 6: 681-92 |
| Meade JA, Free RB, Miller NR, et al. (2015) (-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling. Psychopharmacology. 232: 917-30 |
| Free RB, Chun LS, Moritz AE, et al. (2014) Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor. Molecular Pharmacology. 86: 96-105 |
| Xiao J, Free RB, Barnaeva E, et al. (2014) Discovery, optimization, and characterization of novel D2 dopamine receptor selective antagonists. Journal of Medicinal Chemistry. 57: 3450-63 |
| Conroy JL, Nalwalk JW, Phillips JG, et al. (2013) CC12, a P450/epoxygenase inhibitor, acts in the rat rostral, ventromedial medulla to attenuate morphine antinociception. Brain Research. 1499: 1-11 |
| Bergman J, Roof RA, Furman CA, et al. (2013) Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 445-58 |
| Hough LB, Nalwalk JW, Yang J, et al. (2011) Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic. Pain. 152: 878-87 |